Allergy and airways diseases are major prevalent chronic diseases. In Europe alone, more than 200 million people live with these chronic diseases.

With #ShowLeadership, we encourage stakeholders who could play a role in improving current policies to take action and address the challenges faced by people living with allergy and airways diseases. Only together is change possible.

  • Patients and caregivers, #ShowLeadership by sharing your experiences to inform policy-makers and the wider public about your challenges;
  • Policymakers, #ShowLeadership by supporting and adopting policies that promote prevention and good quality care for people living with allergies and airways diseases;
  • Healthcare professionals, #ShowLeadership by informing the general public and decision-makers about the burden of the disease and the importance of improving care and research.

  • Allergy and asthma are the most common diseases in children, and can last a lifetime.
  • Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the world, among adults over 45.
  • Asthma alone costs €72.2 billion annually in Europe

Our health should be at the core of everything we all do. Unfortunately, we only realise how important being healthy is, when we are sick or feeling unwell. 

The more than 200 million people living with allergy and airways diseases in Europe have been carrying their disease for long time. It is time support them get the control of their lives with the disease.

#ShowLeadership pools together the motivation of patients, carers, healthcare professionals and decision-makers to overcome the situation. EFA Active Patients Access Care survey results show that despite a better understanding of the roots of allergy and an incipient mapping of how asthma and COPD develop, many patients in Europe remain unwell, rely on hospitalisations and feel unprotected against air pollution, chemicals and obesity.

Join us! Whether you are a policy-maker or a public representative, an organisation or an individual, you can make a difference on prevention and care of allergy, asthma and COPD. Only together change is possible.

EFA is the European voice for over 200 million people living with allergies and airway diseases. We bring together national associations from 25 countries and channel their knowledge and demands to European institutions.

In 2019, we launched #ShowLeadership, a pan European communications campaign to highlight the results of EFA’s asthma and COPD survey “Active Patients Access Care”, and a roadmap to encourage targeted action on allergy and airways diseases at European level. 

#Showleadership underpins EFA’s advocacy work. We connect stakeholders to ignite change and bridge the gaps between a wide range of policy issues to support more effective and comprehensive strategies – strategies that address the needs of our community. We strive to achieve greater patient participation in decision-making at local, national and European levels.

We thank our Sustainable Corporate Funders Astra Zeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Sanofi Genzyme and Regeneron for their support to our #ShowLeadership initiative with unrestricted grants.